Literature DB >> 27889588

Preparation and properties evaluation of a novel pH-sensitive liposomes based on imidazole-modified cholesterol derivatives.

Liang Ju1, Fang Cailin2, Wu Wenlan3, Yu Pinghua2, Gao Jiayu2, Li Junbo2.   

Abstract

As a new kind of drug carries, pH-sensitive liposomes have been widely studied in tumor therapy for their advantages of target ability and sustained-release. Here, we synthesized a pH-sensitive material, N-(3-Aminopropyl)imidazole-cholesterol (IM-Chol) and prepared a novel pH-sensitive liposomes using IM-Chol and phosphatidylcholine. IM-Chol was synthesized through amidation reaction between the amino group of N-(3-Aminopropyl)imidazole and acyl chloride group of cholesteryl chloroformate in a weak base solution. Optimal conditions to prepare liposomes were obtained by the orthogonal experiment with the higher encapsulation efficiency as the evaluation indicator. The properties of liposomes, such as particle size, zeta potential, morphology, encapsulation efficiency, drug release behavior and in vitro cell toxicity were evaluated by transmission electron microscopy (TEM), dynamic light scattering (DLS) and MTT assay respectively. The results showed that the average particle size of IM-Chol liposomes was 141nm (PDI 0.323). Liposomes can assemble into uniform spheres at pH 7.4, but under the condition of pH 5.0, the spherical structure of IM-Chol liposomes was broken, exhibiting pH-sensitive property. In vitro drug releasing studies demonstrated the controlled-release behavior of the curcumin (CUR) in the IM-Chol liposomes. The cumulative release of CUR reached to 72.5% in the first 24h at pH 5.0, faster than that at pH 7.4, which confirmed that the drug carrier displayed pH-sensitive release behaviors. In addition, the MTT assay was employed to test the cytotoxicity of IM-Chol liposomes and CUR IM-Chol liposomes. All cell viabilities were greater than 80% after incubating for 24h, even up to the highest dose of 500mg/L, indicating that IM-Chol liposomes had good biocompatibility. The tumor inhibitory results towards EC109 cells of free CUR and CUR-loaded IM-Chol liposomes indicated that IM-Chol liposomes indeed enhanced the cell killing effect of CUR. These results showed that the novel IM-Chol liposomes prepared in this paper had pH-sensitive property and were expected to play a huge potential in tumor treatment.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Curcumin; Drug delivery; Encapsulation efficiency; Imidazolyl-cholesterol (IM-Chol); pH-sensitive liposomes

Mesh:

Substances:

Year:  2016        PMID: 27889588     DOI: 10.1016/j.ijpharm.2016.11.044

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Endogenous Oleoylethanolamide Crystals Loaded Lipid Nanoparticles with Enhanced Hydrophobic Drug Loading Capacity for Efficient Stroke Therapy.

Authors:  Shichao Wu; Di Liao; Xi Li; Zeyu Liu; Lin Zhang; Fong Ming Mo; Shuo Hu; Jian Xia; Xiangrui Yang
Journal:  Int J Nanomedicine       Date:  2021-12-21

2.  Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier.

Authors:  Anshul Dhankher; Wei Lv; William T Studstill; Julie A Champion
Journal:  J Control Release       Date:  2021-09-24       Impact factor: 9.776

Review 3.  Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.

Authors:  Janel Kydd; Rahul Jadia; Praveena Velpurisiva; Aniket Gad; Shailee Paliwal; Prakash Rai
Journal:  Pharmaceutics       Date:  2017-10-14       Impact factor: 6.321

Review 4.  Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications.

Authors:  Yan Chen; Yao Lu; Robert J Lee; Guangya Xiang
Journal:  Int J Nanomedicine       Date:  2020-05-01

Review 5.  The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges.

Authors:  Jiaxi He; Songhui Xu; A James Mixson
Journal:  Pharmaceutics       Date:  2020-08-14       Impact factor: 6.321

6.  Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects.

Authors:  Hong Jiang; Zhi-Peng Li; Gui-Xiang Tian; Rui-Yan Pan; Chong-Mei Xu; Bo Zhang; Jing-Liang Wu
Journal:  Int J Nanomedicine       Date:  2019-03-08

Review 7.  Review of Curcumin Physicochemical Targeting Delivery System.

Authors:  Lanmei Li; Xiaomei Zhang; Chao Pi; Hongru Yang; Xiaoli Zheng; Ling Zhao; Yumeng Wei
Journal:  Int J Nanomedicine       Date:  2020-12-07

8.  Imidazole-Based pH-Sensitive Convertible Liposomes for Anticancer Drug Delivery.

Authors:  Ruiqi Huang; Vijay Gyanani; Shen Zhao; Yifan Lu; Xin Guo
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.